An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma.

Trial Profile

An Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 29 May 2012

At a glance

  • Drugs Hormones; Perifosine; Trastuzumab
  • Indications Multiple myeloma; Solid tumours
  • Focus Adverse reactions
  • Sponsors AEterna Zentaris Inc; AOI Pharmaceuticals; Keryx Biopharmaceuticals
  • Most Recent Events

    • 25 May 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 25 May 2012 Company added in association field as reported by ClinicalTrials.gov.
    • 17 Oct 2011 Planned end date changed from 1 Jul 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top